✦ LIBER ✦

PAR10 COST-EFFECTIVENESS AND COST-UTILITY ANALYSIS OF ANTI-TNF-A DRUGS IN PSORIATIC ARTHRITIS

✍ Scribed by M Eandi; O Zaniolo; S Iannazzo; L Pradelli

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PAR12 A COST-EFFICACY ANALYSIS MODEL FOR

✍ RV Arjunji; OH Dabbous; Ml Rahman 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

PAR10 COST-EFFECTIVENESS OF RITUXIMAB TH

✍ A Kielhorn; A Rubbert; D Porter; S De Vita; B Brown; M Aristides; R Aultman; F J 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

PAR24 COST-UTILITY ANALYSIS OF RITUXIMAB

✍ V Brodszky; M Péntek; K Karpati; I Boncz; A Sebestyén; L Gulácsi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

PMS51 A Cost Utility Analysis of Anti-TN

✍ R.C. Adams; C. Walsh; S. Schmitz; P. Barton; M. Barry 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

PGI6 COST EFFECTIVENESS ANALYSIS OF ANTI

✍ F Xie; G Blackhouse; N Assasi; R Hopkins; K Gaebel; D O'Reilly; JE Tarride; RA G 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB

PAR25 ASSOCIATION OF PERSISTENCE WITH AN

✍ B Tang; MI Rahman; B Meissner; O Dabbous; A Naim; HC Thompson 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB